Improving the Working Environment and Reducing Environmental impacts by Digital transformation of the Production Lines—Shimane Shimadzu Corporation, The Medical System Manufacturing Subsidiary of Shimadzu Co.— Read more
August 9, 2022 QIAseq Targeted DNA Pro Panels halve library preparation time for sequencing samples New low-input kit for RNA sequencing further expands QIAGEN’s universal NGS portfolio and reduces disposable plastics use by 90% Four million samples have been processed by growing range of QIAseq NGS panels running on any sequencer Hilden, Germany, and Germantown,... Read more
08.09.22 BOSTON–(BUSINESS WIRE)–908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces that it has completed the acquisition of privately-held TRACE Analytics GmbH, based in Braunschweig, Germany, a provider of on-line analysis and sampling systems for biotech applications. 908 Devices expects the acquired technology to... Read more
Toronto, Canada – August 9 – Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector. The... Read more
CHELMSFORD, Mass., Aug. 8, 2022 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries (“B Medical”), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to... Read more
This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more
The human genome contains ~20,000 genes that encode the proteins responsible for cellular and organismal function. Dysregulation of gene expression is a frequent cause of disease; for example, overexpression of an oncogene may result in cancer. However, it has been challenging to understand how gene expression is regulated in mammals, because the key regulatory regions... Read more
August 03, 2022 HERCULES, Calif.–(BUSINESS WIRE)– Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland,... Read more
Q2 2022 reported revenue growth of 3.1% year-over-year (yoy); organic revenue growth of 8.8% Q2 2022 GAAP EPS $0.33; non-GAAP EPS $0.45, up 2.3% yoy Maintaining FY 2022 guidance for high, single-digit organic revenue growth, non-GAAP operating profit margin expansion and non-GAAP EPS increase BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced financial results... Read more